Liangqin Guo - Concepedia

Author

Liangqin Guo

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Liangqin Guo

Publications

698

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)United States Military Academy

About

Liangqin Guo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	388
2	Biochemistry	12	12	309
3	Natural Sciences	7	7	174
4	Health Sciences	2	2	31
5	Engineering	1	1	48

Liangqin Guo

Publications

678

Citations

H-Index

Page 1

	Year	Citations
Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2 Lihu Yang, Scott C. Berk, Susan P. Rohrer, Proceedings of the National Academy of Sciences	1998	128
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors Qinglin Pu, Hongjun Zhang, Liangqin Guo, ACS Medicinal Chemistry Letters	2020	82
Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα Kevin D. Dykstra, Liangqin Guo, Elizabeth T. Birzin, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistrySubtype Selective LigandsMedicineHormonal Receptor	2007	67
Spiro[1<i>H</i>-indene-1,4‘-piperidine] Derivatives As Potent and Selective Non-Peptide Human Somatostatin Receptor Subtype 2 (sst<sub>2</sub>) Agonists Lihu Yang, Liangqin Guo, Alexander Pasternak, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryNatural SciencesPharmacology	1998	54
Palladium-catalyzed Annulation of Oxygen-Substituted 1,3-Dienes Richard C. Larock, Liangqin Guo Synlett Oxygen-substituted 1,3-DienesChemical EngineeringCross-coupling ReactionEngineeringAlkene Metathesis	1995	48
Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist Zhixiong Ye, Liangqin Guo, Khaled J. Barakat, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural Sciences	2005	37
Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists Lihu Yang, Changyou Zhou, Liangqin Guo, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryPotent Ccr2 AntagonistsMedicinePharmacotherapy	2006	26
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes Shrenik K. Shah, Shuwen He, Liangqin Guo, ACS Medicinal Chemistry Letters Development CandidateCardiovascular PharmacologyPharmacotherapyExperimental PharmacologyTranslational Pharmacology	2015	23
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist Shuwen He, Zhixiong Ye, Peter H. Dobbelaar, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryFunctional SelectivityMedicineNatural Sciences	2010	23
Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity Shuwen He, Zhixiong Ye, Peter H. Dobbelaar, Bioorganic & Medicinal Chemistry Letters BiochemistryFunctional SelectivitySpiroindane N-me-1,2,4-triazoleMedicineRational Drug Design	2010	20

Page 1